|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 591.60 INR | -0.57% |
|
+1.60% | +34.04% |
| 05-22 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 41.89B 434M 381M 352M 324M 611M 621M 4.21B 1.65B 20.5B 1.63B 1.6B 70.62B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 44B 456M 400M 370M 340M 641M 652M 4.42B 1.73B 21.53B 1.71B 1.68B 74.17B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.71% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -0.57% | ||
| 1 week | +1.60% | ||
| Current month | +27.39% | ||
| 1 month | +32.04% | ||
| 3 months | +70.12% | ||
| 6 months | +57.05% | ||
| Current year | +34.04% |
| 1 week | 575 |  | 625 |
| 1 month | 424.6 | | 685.95 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 07/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 21/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 09/08/2023 |
| Director/Board Member | 57 | 09/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.57% | +1.60% | -5.28% | +55.48% | 434M | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,023B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 599B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 448B | |
| -0.60% | +0.30% | +28.32% | +21.15% | 326B | |
| +1.18% | -1.19% | +33.38% | +35.35% | 278B | |
| -0.53% | -1.82% | +20.26% | +15.74% | 258B | |
| -1.02% | +1.11% | -20.89% | -40.59% | 222B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 197B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 165B | |
| Average | -0.36% | -0.38% | +23.69% | +48.32% | 351.55B | |
| Weighted average by Cap. | -0.58% | -1.18% | +35.16% | +70.58% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 219M 192M 177M 163M 308M 313M 2.12B 831M 10.33B 822M 804M 35.59B | 22.02B 228M 200M 185M 170M 321M 326M 2.21B 867M 10.77B 857M 839M 37.12B |
| Net income | 1.38B 14.26M 12.5M 11.55M 10.63M 20.05M 20.37M 138M 54.16M 673M 53.55M 52.38M 2.32B | 2.53B 26.22M 22.98M 21.24M 19.54M 36.86M 37.45M 254M 99.57M 1.24B 98.46M 96.31M 4.26B |
| Net Debt | 3.7B 38.39M 33.65M 31.1M 28.61M 53.97M 54.84M 372M 146M 1.81B 144M 141M 6.24B | 2.11B 21.85M 19.15M 17.7M 16.28M 30.72M 31.21M 212M 82.97M 1.03B 82.03M 80.25M 3.55B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/07/26 | ₹591.60 | -0.57% | 3,497 |
| 20/07/26 | ₹595.00 | +0.86% | 4,385 |
| 17/07/26 | ₹589.95 | -2.50% | 13,469 |
| 16/07/26 | ₹605.05 | +1.71% | 7,482 |
| 15/07/26 | ₹594.90 | +2.16% | 11,394 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
